HIGH-VOLUME · HOSP-HEAVY

apixaban Side Effects

apixaban (also sold as Eliquis) is HIGH-VOLUME in this FAERS book #118 of 524 by FAERS report count. Signature opener: HOSP-HEAVY - 43.9% mention hospitalization (27,509 reports).

Data updated 2026-05-15

62,650
FAERS reports

FAERS voluntary reports, 2005 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.

apixaban: 43.9% mention hospitalization (27,509 reports). Death stamp DEATH-HEAVY; volume band HIGH-VOLUME #118 of 524 by FAERS report count.

High-report extract for apixaban (Eliquis): 62,650 FAERS rows (2005-2025). Top named reactions: ATRIAL FIBRILLATION, DYSPNOEA, CEREBROVASCULAR ACCIDENT. Outcome stamps DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED. FAERS is voluntary signal detection, not incidence.

Counts from the openFDA FAERS extract (2005–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.

ATRIAL FIBRILLATION leads 3,970 of 62,650 reports

ATRIAL FIBRILLATION
3,970
DYSPNOEA
3,598
CEREBROVASCULAR ACCIDENT
3,508
THROMBOSIS
2,806
CARDIAC DISORDER
2,509
DEATH
2,332
FALL
2,287
FATIGUE
2,193
DIZZINESS
1,929
ANAEMIA
1,910
DIARRHOEA
1,768
NAUSEA
1,679
ACUTE KIDNEY INJURY
1,673
HEADACHE
1,591
COVID-19
1,555
PULMONARY EMBOLISM
1,542
GASTROINTESTINAL HAEMORRHAGE
1,535
DRUG INTERACTION
1,524

Who reports · age peak 75+ (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 27,064 (47%)
Male 30,594 (53%)
Unknown 20

Age peak 75+ (21,179 reports)

0-17 457 (1%)
18-44 1,817 (4%)
45-64 8,208 (19%)
65-74 12,224 (28%)
75+ 21,179 (48%)

FAERS filings rising toward 2025

2005 2025

Reactions in Death Reports

Death-mentioned subset is HEAVY here (6,759 reports, 10.8%). Top co-reported reactions in that subset - voluntary, not causal.

Reaction Reports
DEATH 2,331
PNEUMONIA 296
FALL 280
ACUTE KIDNEY INJURY 276
DYSPNOEA 268
CEREBRAL HAEMORRHAGE 262
CARDIAC FAILURE 247
CARDIAC ARREST 214
ANAEMIA 192
COMPLETED SUICIDE 190
SEPSIS 188
SEPTIC SHOCK 188
GASTROINTESTINAL HAEMORRHAGE 176
HAEMORRHAGE INTRACRANIAL 172
HYPOTENSION 170
TOXICITY TO VARIOUS AGENTS 161
RESPIRATORY FAILURE 148
GENERAL PHYSICAL HEALTH DETERIORATION 147
CEREBROVASCULAR ACCIDENT 140

Reactions in Hospitalization Reports

Hospitalization is HEAVY (27,509, 43.9% of the book). Top reactions in those rows:

Reaction Reports
DYSPNOEA 2,426
ATRIAL FIBRILLATION 1,760
ANAEMIA 1,600
FALL 1,576
ACUTE KIDNEY INJURY 1,394
FATIGUE 1,167
DIZZINESS 1,098
GASTROINTESTINAL HAEMORRHAGE 1,048
PNEUMONIA 1,047
HYPOTENSION 1,042
GENERAL PHYSICAL HEALTH DETERIORATION 1,021
DIARRHOEA 1,019
CONDITION AGGRAVATED 912
NAUSEA 904
CARDIAC FAILURE 818
DRUG INTERACTION 801
PYREXIA 800
VOMITING 778
How to read apixaban FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-HEAVY)

FAERS holds 62,650 voluntary reports linked to apixaban (Eliquis), 2005-2025. Death is listed on 6,759 (10.8%). Hospitalization appears on 27,509 (43.9%). Top co-reported indication: Product Used For Unknown Indication.

CASELOAD books overweight common drugs and loud reporting cultures; HOSP-HEAVY is the page opener, not a per-patient risk.

Read with apixaban

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.